Webcode 26102002
Dr. Willi Schnorpfeil
WS Value & Dossier GmbH
Owner
More information please click here.
Victoria Unmüßig
Astellas Pharma GmbH
EU HTA Lead; Global Access & Value and Public Policy
More information please click here.
Anne Martin
J&J Innovative Medicine
Director Contracting, Price & Analytics Hub
Mona Glogger
AccessMatters GmbH
Managing Partner;
Mona Glogger is managing partner of AccessMatters GmbH, a specialized consulting company in the areas of pharmaceutical market access, reimbursement, HTA, and pricing in Germany-all embedded within European and global commercial business strategy. Mona held held various leadership industry positions at different companies such as Bristol Myers Squibb, Celgene, AbbVie - from market access to HTA and pricing. With more than 10 years of industry experience, Mona has successfully supported product launches in cross-functional matrix teams from a business perspective and advocates for a broad understanding of market access in order to successfully and sustainably navigate complex market access environments.
More information please click here.
20 - 21/10/2026
20 - 21/10/2026
Day 1: 09:00 am - 05:00 pm
Day 2: 09:00 am - 01:30 pm
online
online
Event - 1,690€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
SPECIAL OFFER
e-Learning: AMNOG briefly and concisely
, online
Your booking advantage:
You book the seminar as usual and add the e-learning module "AMNOG briefly and concisely". The price of the e-learning is reduced by € 100.00 (€ 390.00 instead of € 490.00 plus VAT)
390,00 €
Event - 1,690€ plus tax
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
SPECIAL OFFER
e-Learning: AMNOG briefly and concisely
, online
Your booking advantage:
You book the seminar as usual and add the e-learning module "AMNOG briefly and concisely". The price of the e-learning is reduced by € 100.00 (€ 390.00 instead of € 490.00 plus VAT)
390,00 €
Dr. Henriette Wolf-Klein
Department Manager
+49 6221 500-680
h.wolf-klein@forum-institut.de
Market Access of innovative medicines in Europe - here you will learn the key concepts from strategy to roll-out.
Gain a solid foundation in market access at EU and national level - focused on innovative medicines.
Four industry experts will guide you through the European payer landscape: financial models, payer archetypes, and HTA implications. Germany's HTA system serves as a deep-dive example of a value-based market.
Leave with strategic and operational know-how to drive your next launch from a market access perspective.
09:00 Welcome and introduction
09:20
Anne Martin
12:30 Lunch break
13:30
Dr Willi Schnorpfeil
14:50 Coffee break
15:20
Victoria Unmüßig
17:00 End of day one
09:00
Mona Glogger
10:15 Coffee break
10:45
Dr Willi Schnorpfeil
12:00 Short break
12:15
Mona Glogger
13:30 End of day 2
of 5 stars of all ratings from 2025
of 5 stars on Trustpilot = good
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...
Biosimilar uptake in Europe, Aut idem in Germany - these are the challenges for regulatory affairs and market access
This seminar equips medical device professionals with a clear regulatory and operational roadmap for clinical evaluation...
This e-Learning programme will provide you with knowledge on Good Distribution Practice in today's pharmaceutical indust...
Boost your impact in European drug launches with this interactive Medical Affairs seminar on communication, cross-functi...
